CG Oncology
CGON
CGON
161 hedge funds and large institutions have $1.97B invested in CG Oncology in 2025 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 77 increasing their positions, 28 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 142 → 161 (+19)
6.75% more ownership
Funds ownership: 92.84% → 99.59% (+6.8%)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
Holders
161
Holding in Top 10
9
Calls
$21.7M
Puts
$7.88M
Top Buyers
| 1 | +$33.6M | |
| 2 | +$31.6M | |
| 3 | +$24.1M | |
| 4 |
Morgan Stanley
New York
|
+$22.2M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$18.4M |
Top Sellers
| 1 | -$59.2M | |
| 2 | -$30.3M | |
| 3 | -$23.2M | |
| 4 |
DM
Deerfield Management
New York
|
-$20.8M |
| 5 |
O
OrbiMed
New York
|
-$14.3M |